Meetings - The ASCO Post

Though many case studies and anecdotal reports have touted the effectiveness of cannabinoids for cancer pain, in randomized studies, the areas in which they are effective are “fairly borderline,” acc...

Supportive Care

By Meg Barbor, MPH / August 25, 2018 / MASCC/ISOO 2018

Cannabinoids for Cancer Pain: Dangerous or Beneficial?

Cannabis has been used in health care for millennia, and its use has been well documented, albeit never definitively integrated into clinical practice. Recent societal changes and the increasing accep...

Supportive Care

By Meg Barbor, MPH / August 25, 2018 / MASCC/ISOO 2018

Therapeutic Applications for Cannabinoids in Oncology: The Debate Continues

In the early part of the 20th century, the U.S. government classified cannabis as a Schedule 1 drug: a dangerous substance with no medical value. For many years, that classification prevented systemat...

MASCC/ISOO 2018

Expert Point of View: Ian Olver, AM, MD, PhD

Cannabinoids for Cancer Pain: Dangerous or Beneficial?

Therapeutic Applications for Cannabinoids in Oncology: The Debate Continues

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors